Article
Resequencing the APOE gene reveals that rare mutations are not significant contributory factors in the development of type III hyperlipidemia.
Journal of clinical lipidology - 1 Jan 2000
Evans David, Beil Frank Ulrich, Aberle Jens
Abstract excerpt
BACKGROUND: APOE (apolipoprotein E gene) 2/2 genotype and an apolipoprotein B/total cholesterol (ApoB/TC) ratio <0.15 are diagnostic for type III hyperlipidemia. We hypothesized that patients with APOE genotype 2/3 or 2/4 and an ApoB/TC ratio <0.15 may have a mutation in their epsilon 3 or 4 alle...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
